| PACKAGING TYPE: | 20x10 Blister (20 Strips In 1 Box) |
| COMPOSITION: | Glimepiride 1mg+metformin 500mg |
| FORMULATION: | Tablet |
| Description: | MEPRIMET M1 Tablet is a dual-combination antidiabetic medication containing: Glimepiride 1mg – a sulfonylurea that stimulates insulin secretion from pancreatic beta cells. Metformin 500mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity. This combination is used for the management of Type 2 Diabetes Mellitus, particularly in patients who require enhanced blood sugar control beyond what monotherapy can provide. It effectively controls both fasting and postprandial blood glucose levels, helping reduce the risk of long-term diabetic complications. |
| Side Effects: | Common side effects: Nausea, diarrhea, or mild gastrointestinal discomfort Headache or dizziness Hypoglycemia (due to Glimepiride) Rare but serious side effects: Lactic acidosis (rare, due to Metformin) Severe hypoglycemia Liver or kidney function abnormalities Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take MEPRIMET M1 Tablet orally, usually once or twice daily with meals or as prescribed. Swallow the tablet whole with water. Do not skip meals to avoid hypoglycemia. Maintain a healthy diet and regular exercise routine. Monitor blood glucose levels regularly. |
| Precaution: | Monitor for symptoms of hypoglycemia (sweating, dizziness, confusion). Use cautiously in patients with kidney or liver impairment. Avoid excessive alcohol consumption (risk of lactic acidosis). Inform your doctor about all medications to avoid interactions. Not recommended during pregnancy or breastfeeding without medical advice. |
| Product Benefits: | Provides dual-action blood sugar control. Reduces fasting and postprandial glucose levels. Enhances insulin secretion and insulin sensitivity. Reduces the risk of diabetes-related complications. Suitable for patients not adequately controlled on diet, |
Frequently Asked Questions
It is used to manage Type 2 Diabetes Mellitus with dual-drug therapy for better control.
Yes, Glimepiride may cause hypoglycemia, especially if meals are skipped.
MEPRIMET M1 contains Metformin 500mg in combination with Glimepiride 1mg, offering dual-action blood sugar control.











